Albany Molecular Research Inc. (AMRI) has signed a deal to provide sterile fill-and-finish services for AstraZeneca’s COVID-19 vaccine candidate, AZD1222. AMRI will do the work at its facility in Albuquerque, New Mexico. Meanwhile, Inovio has picked Thermo Fisher Scientific to manufacture its DNA COVID-19 vaccine candidate, INO-4800. Thermo Fisher will make the active ingredient and provide fill-and-finish services at plants in the US. Both AstraZeneca and Inovio have several other production partners.
Support nonprofit science journalism
C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. To support us:
Donate Join Subscribe